Christopher L Gaenzle's Net Worth

$11.1 Million

Estimate Recalculated Sep 8, 2024 07:30PM EST

Who is Christopher L Gaenzle?

Christopher L Gaenzle has an estimated net worth of $11.1 Million. This is based on reported shares across multiple companies, which include INC Research Holdings, Inc., and PRA Health Sciences, Inc..

SEC CIK

Christopher L Gaenzle's CIK is 0001624044

Past Insider Trading and Trends

2017 was Christopher L Gaenzle's most active year for acquiring shares with 13 total transactions. Christopher L Gaenzle's most active month to acquire stocks was the month of May. 2017 was Christopher L Gaenzle's most active year for disposing of shares, totalling 28 transactions. Christopher L Gaenzle's most active month to dispose stocks was the month of May. 2021 saw Christopher L Gaenzle paying a total of $5,486,648.76 for 71,221 shares, this is the most they've acquired in one year. In 2021 Christopher L Gaenzle cashed out on 242,997 shares for a total of $10,022,841.46, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

INC Research Holdings, Inc. No price found

CAO, GC & Sec

Christopher L Gaenzle owns 52,722 units of Class A Common Stock.acquired a total of 224,578 shares in INC Research Holdings, Inc. at a cost of $1,926,848.57, Christopher also disposed a total of 171,856 shares of INC Research Holdings, Inc. equalling to $8,340,821.60.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-1.70%
-912.00
$40.75
-$37,164.00
52.72K
Jan 29
Form 4
-4.05%
-2.26K
$40.96
-$92,703.70
53.63K
Scheduled
Jan 19 - Jan 22
Form 4
-13.77%
-8.93K
$54.70
-$488,264.76
55.9K
Scheduled
Sep 15 - Sep 18
Form 4
—
0
$36.06
-$1,926,360.20
64.82K
Scheduled
Sep 1
Form 4
—
0
—
—
0
Aug 10
Form 4
+39.42%
18.33K
—
—
64.82K
Aug 1
Form 4
-3.77%
-1.82K
$37.20
-$356,538.62
46.49K
Scheduled
Jun 30 - Jul 3
Form 4
—
0
$28.14
-$166,270.29
48.32K
Scheduled
Apr 3
Form 4
+23.77%
9.28K
—
—
48.32K
Jan 27
Form 4
-5.48%
-2.26K
$50.31
-$113,847.90
39.04K
Scheduled
Jan 19 - Jan 20
Form 4
—
0
$32.21
-$605,750.79
41.3K
Scheduled
Jan 3
Form 4
+184.47%
26.78K
$26.60
-$156,610.19
41.3K
Scheduled
Sep 14 - Sep 15
Form 4
-7.73%
-1.22K
$27.75
-$564,572.47
14.52K
Scheduled
Jul 11
Form 4
-3.71%
-606.00
$38.13
-$23,106.78
15.73K
Jun 30
Form 4
—
0
$27.45
-$195,481.55
16.34K
Scheduled
Jun 14 - Jun 15
Form 4
+124.13%
9.05K
—
—
16.34K
Jan 19
Form 4
—
0
$29.25
-$358,545.02
7.29K
Scheduled
Dec 31
Form 4
—
0
$26.06
-$791,841.39
7.29K
Scheduled
Dec 7 - Dec 8
Form 4
—
0
$25.75
-$536,915.37
7.29K
Scheduled
Aug 31
Form 4
∞
7.29K
—
—
7.29K
Jun 30
Form 3
—
0
—
—
0
No matching records found

PRA Health Sciences, Inc. No price found

EVP, CAO & General Counsel

Christopher L Gaenzle used to own units in Common Stock but no longer holds any shares there. In the year 2020 Christopher L Gaenzle filed a total of 8 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-34.50K
—
—
0
Jul 1
Form 4
—
0
$134.77
-$1,864,019.82
34.5K
Scheduled
Jun 17
Form 4
-5.41%
-1.97K
$134.14
-$2,119,484.94
34.5K
Scheduled
Jun 15 - Jun 16
Form 4
+5.72%
1.97K
$170.45
-$144,882.50
36.47K
Jun 1
Form 4
-8.33%
-3.14K
$130.04
-$407,805.44
34.5K
Scheduled
Jan 8
Form 4
-3.50%
-1.36K
$102.88
-$140,328.32
37.64K
Aug 13
Form 4
—
0
—
—
0
Jun 1
Form 3
—
0
—
—
0
No matching records found